| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75235
The androgen receptor (AR) is present in many cells in two forms. The B form migrates with an apparent mass of 110 kDa and constitutes more than 80% of the immunoreactive receptor in most cell types. The A form of the AR migrates with an apparent mass of 87 kDa, appears to derive from internal translation initiation at methionine-188 in the AR open-reading frame, and usually constitutes 20% or less of the immunoreactive AR present. Previous experiments designed to examine the functional capacity of the A and B forms of the AR have been hampered by marked differences in the expression levels of the two isoforms, as the nucleotide sequence surrounding the codon encoding methionine-188 causes it to be used inefficiently as a translation initiation site. To circumvent this, we altered the nucleotide sequence surrounding methionine-188 to render it more similar to that surrounding the codon encoding methionine-1. Transfection of a cDNA containing these changes resulted in similar levels of expression of A and B forms of the AR as assessed by immunoblot assays using antibodies directed at an epitope preserved in both. Functional activities of these cDNAs were assessed using cotransfection assays that employed two model androgen-responsive genes (MMTV-luciferase and PRE2-tk-luciferase) in response to mibolerone, a potent androgen agonist, in three different cell lines. These studies demonstrated subtle differences in the activities of the A and B isoforms, which depended on the promoter and cell context. Additional studies failed to reveal any major differences in the responses of the AR-A and AR-B isoforms to a variety of androgen agonists and antagonists, suggesting that the previously reported functional defect of the AR-A is due principally to its level of expression. When assays of AR function are performed under conditions in which levels of expression of the two isoforms are equivalent, the AR-A and AR-B possess similar functional activities.
This article has been cited by other articles:
 |
|
 |
|
  S. Aquila, E. Middea, S. Catalano, S. Marsico, M. Lanzino, I. Casaburi, I. Barone, R. Bruno, S. Zupo, and S. Ando Human sperm express a functional androgen receptor: effects on PI3K/AKT pathway Hum. Reprod., October 1, 2007; 22(10): 2594 - 2605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al. International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Gatson, P. Kaur, and M. Singh Dihydrotestosterone Differentially Modulates the Mitogen-Activated Protein Kinase and the Phosphoinositide 3-Kinase/Akt Pathways through the Nuclear and Novel Membrane Androgen Receptor in C6 Cells Endocrinology, April 1, 2006; 147(4): 2028 - 2034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Servert, J. Garcia-Castro, V. Diaz, D. Lucas, M. A. Gonzalez, C. Martinez-A, and A. Bernad Inducible model for {beta}-six-mediated site-specific recombination in mammalian cells Nucleic Acids Res., January 3, 2006; 34(1): e1 - e1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Buchanan, S. N. Birrell, A. A. Peters, T. Bianco-Miotto, K. Ramsay, E. J. Cops, M. Yang, J. M. Harris, H. A. Simila, N. L. Moore, et al. Decreased Androgen Receptor Levels and Receptor Function in Breast Cancer Contribute to the Failure of Response to Medroxyprogesterone Acetate Cancer Res., September 15, 2005; 65(18): 8487 - 8496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Modugno Ovarian Cancer and Polymorphisms in the Androgen and Progesterone Receptor Genes: A HuGE Review Am. J. Epidemiol., February 15, 2004; 159(4): 319 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Brenowitz and K. Lent Act locally and think globally: Intracerebral testosterone implants induce seasonal-like growth of adult avian song control circuits PNAS, September 17, 2002; 99(19): 12421 - 12426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Qi, C. Fillion, Y. Labrie, J. Grenier, A. Fournier, L. Berger, M. El-Alfy, and C. Labrie AIbZIP, a Novel bZIP Gene Located on Chromosome 1q21.3 That Is Highly Expressed in Prostate Tumors and of Which the Expression Is Up-Regulated by Androgens in LNCaP Human Prostate Cancer Cells Cancer Res., February 1, 2002; 62(3): 721 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. McPhaul Molecular Defects of the Androgen Receptor Recent Prog. Horm. Res., January 1, 2002; 57(1): 181 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF]
|
|
|
|
|
|
M. J. McPhaul and J. E. Griffin Male Pseudohermaphroditism Caused by Mutations of the Human Androgen Receptor J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3435 - 3441. [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Zhu, L.-Q. Cai, J. J. Cordero, W. J. Canovatchel, M. D. Katz, and J. Imperato-McGinley A Novel Mutation in the CAG Triplet Region of Exon 1 of Androgen Receptor Gene Causes Complete Androgen Insensitivity Syndrome in a Large Kindred J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1590 - 1594. [Abstract] [Full Text]
|
|
|
|
|
|
T. S. Sperry and P. Thomas Characterization of Two Nuclear Androgen Receptors in Atlantic Croaker: Comparison of Their Biochemical Properties and Binding Specificities Endocrinology, April 1, 1999; 140(4): 1602 - 1611. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
